Various techniques are employed to detect metabolic imbalances in cancer. Positron Emission Tomography (PET) scans using fluorodeoxyglucose (FDG) can visualize increased glucose uptake in tumors. Additionally, metabolomics and proteomics approaches can identify altered metabolic profiles and enzyme expression levels in cancer tissues.
